BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 27701420)

  • 1. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
    Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA
    Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
    Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
    Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new chemical class of antimalarials.
    Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
    J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds.
    Malebo HM; D'Alessandro S; Ebstie YA; Sorè H; Tenoh Guedoung AR; Katani SJ; Parapini S; Taramelli D; Habluetzel A
    Drug Des Devel Ther; 2020; 14():1593-1607. PubMed ID: 32425505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.
    O'Neill PM; Amewu RK; Charman SA; Sabbani S; Gnädig NF; Straimer J; Fidock DA; Shore ER; Roberts NL; Wong MH; Hong WD; Pidathala C; Riley C; Murphy B; Aljayyoussi G; Gamo FJ; Sanz L; Rodrigues J; Cortes CG; Herreros E; Angulo-Barturén I; Jiménez-Díaz MB; Bazaga SF; Martínez-Martínez MS; Campo B; Sharma R; Ryan E; Shackleford DM; Campbell S; Smith DA; Wirjanata G; Noviyanti R; Price RN; Marfurt J; Palmer MJ; Copple IM; Mercer AE; Ruecker A; Delves MJ; Sinden RE; Siegl P; Davies J; Rochford R; Kocken CHM; Zeeman AM; Nixon GL; Biagini GA; Ward SA
    Nat Commun; 2017 May; 8():15159. PubMed ID: 28537265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
    Edgar RCS; Malcolm TR; Siddiqui G; Giannangelo C; Counihan NA; Challis M; Duffy S; Chowdhury M; Marfurt J; Dans M; Wirjanata G; Noviyanti R; Daware K; Suraweera CD; Price RN; Wittlin S; Avery VM; Drinkwater N; Charman SA; Creek DJ; de Koning-Ward TF; Scammells PJ; McGowan S
    mBio; 2024 Jun; 15(6):e0096624. PubMed ID: 38717141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment
    Yipsirimetee A; Chiewpoo P; Tripura R; Lek D; Day NPJ; Dondorp AM; Pukrittayakamee S; White NJ; Chotivanich K
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0148121. PubMed ID: 34978886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
    Basilico N; Parapini S; Sparatore A; Romeo S; Misiano P; Vivas L; Yardley V; Croft SL; Habluetzel A; Lucantoni L; Renia L; Russell B; Suwanarusk R; Nosten F; Dondio G; Bigogno C; Jabes D; Taramelli D
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29194347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.
    Schleiferböck S; Scheurer C; Ihara M; Itoh I; Bathurst I; Burrows JN; Fantauzzi P; Lotharius J; Charman SA; Morizzi J; Shackleford DM; White KL; Brun R; Wittlin S
    Drug Des Devel Ther; 2013; 7():1377-84. PubMed ID: 24255594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
    Yipsirimetee A; Tipthara P; Hanboonkunupakarn B; Tripura R; Lek D; Kümpornsin K; Lee MCS; Sattabongkot J; Dondorp AM; White NJ; Kobylinski KC; Tarning J; Chotivanich K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0173022. PubMed ID: 37338381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplasmodial efficacy of
    Satish PVV; Kumari DS; Sunita K
    J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.